Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Showing results for

An internationally recognised centre of excellence for biomedical and clinical research and teaching

Umbrella review of traumatic brain injury research

Lead author Maya Ogonah outlines the findings from her research into traumatic brain injuries which has been published in the journal Nature Mental Health.

Bursary will honour Professor Valentine Macaulay

A bursary has been established to honour the memory of the late Professor Valentine (Val) Macaulay who made incredible contributions to prostate cancer research.

New study reveals the COVID-19 pandemic’s impact on other causes of death

An international study involving researchers at the Leverhulme Centre for Demographic Science has found significant effects of the COVID-19 pandemic on many causes of death across 24 countries.

Radical rethink of mental health support for adolescents needed – new study

Young people have given important insights into what mental health support they prefer and what does not work for them or meet their needs, as part of a major new study of thousands of adolescents.

A way to test the ability of red blood cells to deliver oxygen by measuring their shape

Scientists have developed a way of assessing the ability of red blood cells to deliver oxygen by measuring their shape. This test could improve specialist transplant and transfusion practice as well as blood banking. The research is now published open access in eBioMedicine – part of the Lancet Discovery Science.

Oxford study identifies the most effective treatments for ADHD in adults

Atomoxetine and a class of drug known as stimulants are the most effective treatments in the management of attention deficit hyperactivity disorder (ADHD) symptoms in adults, according to a new study.

Christmas Case Study

Research from the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) may have had an unanticipated secondary effect by saving Christmas.

The genetic basis of fertility, family and longevity

A new review by researchers from Oxford Population Health and the University of Iceland, published in Nature Aging, reveals how your DNA shapes reproductive health, fertility, and even life expectancy.

Can we get to overseas conferences without wrecking the planet?

Two Oxford researchers share their eye-opening journey to a conference in Marrakesh by train and ferry instead of flying. Discover the challenges, unexpected joys, and compelling environmental case for low-carbon academic travel.

Mei Nortley awarded inaugural Averil Mansfield Trainer of the Year Award

Ms Mei Nortley, Deputy Director of Teaching in Surgery at the Nuffield Department of Surgical Sciences, has been presented with the inaugural Averil Mansfield Trainer of the Year Award 2024.

Alethiomics – using Artemis to hunt down blood cancers

Spin-out company Alethiomics, focused on the development of innovative treatments for blood cancers, is Oxford through-and-through. Founded by Clinician Scientists who run neighbouring laboratories at the University’s MRC Weatherall Institute of Molecular Medicine, seed financed by Oxford Science Enterprises and located at the BioEscalator, the company’s early years have been immersed in the Oxford innovation ecosystem.

Research Excellence Framework (REF) Panel Update

Oxford and partners lead on two new MRC Centres to create cutting-edge gene therapies

Oxford University researchers are to lead and co-lead on two MRC research centres, which are being launched to develop new advanced treatments for currently untreatable diseases.

MSD Research Staff Forum update: Sharing activities that help researchers

First vaccine against blood-stage malaria is well-tolerated and offers effective protection

The results of a clinical trial into a new malaria vaccine candidate (RH5.1/Matrix-MTM) show it is well-tolerated and offers effective protection against the blood-stage of the disease - the first inoculation to do so.

The Kavli Oxford Lecture Award 2024 Recognises Regina E. Dugan for Breakthroughs in Human Health Innovation

The Kavli Oxford Lecture Award, an annual celebration of scientific achievement and inspiration, marked its third year with a captivating keynote delivered by Regina Dugan, CEO of Wellcome Leap. A pioneering leader in health innovation, Regina inspired the audience by demonstrating how differences could be made by accelerating breakthroughs in human health.

Wearable devices can help predict five year risk of falls for people with Parkinson’s Disease

A new study from the University of Oxford demonstrates how clinicians could use data to predict the risk of falls in people with Parkinson’s Disease (PD) to help improve effective longer term care planning.

Predicting Response to Rectal Cancer Treatment through the S:CORT consortium

Recent research from the S:CORT team spanning three publications has identified key biomarkers and treatment strategies that predict and enhance effectiveness of radiotherapy in rectal cancer treatment.

Department of Pharmacology research leads to FDA approval for new NPC treatment

A Department of Pharmacology start-up company has received approval from the US Food and Drug Administration (FDA) for a new treatment for the rare lysosomal storage disorder Niemann-Pick Disease Type C (NPC) in both adults and children.

Renewal of the Novo Nordisk – University of Oxford Fellowship Programme

Leading global healthcare company Novo Nordisk has deepened its partnership with the University of Oxford by announcing £18.5 million of funding for a further 20 Postdoctoral Fellows in this prestigious scientific research programme, over the next nine years. This expanded collaboration also introduces an innovative ‘Springboard Fellowship’, which offers selected fellows an extra two years of funding to further advance their research and professional development.

Load More